Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 2 heures

IBM tech explains why some cancer cells die in response to treatment and others don’t

Hier à 19:24
Several cancer drugs work by promoting “apoptosis,” or programmed cell death. Researchers at Mount Sinai, working with IBM, found a link between responses to those treatments and mitochondria, the...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 16:57

Unlocking the Potential of Fast DNA Synthesis

Il y a 6 jours
While the price and speed of reading DNA have dropped massively, writing DNA fast and affordably still remains a challenge. Philip talked to Sylvain Gariel, COO of the French company DNA Script, who...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 15:43

Epic Sciences nets Myriad’s cancer president to serve as its CEO

Hier à 19:23
Liquid biopsy developer Epic Sciences has brought on Myriad Genetics’ oncology chief, Lloyd Sanders, to be its new president and CEO....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 14:05

Agios blood cancer drug lead jumps ship to Aprea Therapeutics

Hier à 19:24
Swedish p53 cancer biotech Aprea Therapeutics has nabbed former Agios senior medical director Eyal Attar as its senior vice president and chief medical officer....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 12:12

Where Does Brexit Leave European Biotech?

Hier à 19:24
In the next couple of months, the UK will officially exit the EU, in a move that is popularly known as Brexit. With this date fast approaching, companies, organizations and individuals all over the...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 11:52

Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work

Hier à 19:24
Just weeks after kick-starting its phase 1 test, Arch Oncology has gathered $50 million in financing to help see its immuno-oncology asset through the clinic....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

Hier à 19:24
The failure of Biogen’s Alzheimer’s disease drug in a phase III trial last week caused BioArctic’s stock price to plummet by 35% on Nasdaq Stockholm. The Swedish company has just begun a phase III...
labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Aujourd'hui à 07:36

Thermo Fisher to buy viral vector maker Brammer Bio for $1.7B

Hier à 19:24
Thermo Fisher Scientific has moved to acquire viral vector developer and manufacturer Brammer Bio for $1.7 billion in cash, giving it a new foothold in the cell and gene therapy market....
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Hier à 19:48

CRISPR diagnostic maker Sherlock Biosciences says the game’s afoot with $35M launch

Il y a 4 jours
Sherlock Biosciences is launching with $35 million and a two-pronged approach to improving the current state of diagnostics, with the goal of creating new tools that “reach further out, where testing...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 16:57

Danish Startup Gets €5.5M to Produce Hard-to-Make Chemicals Through Fermentation

Il y a 4 jours
CysBio is developing a fermentation technology to produce valuable chemicals that were previously too difficult or expensive to make. Founded just at the beginning of this year, CysBio is now...
labiotech.eu
Charger plus d'actualités